US 12230379
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted A61KA61K35/13A61K40/11
Quick answer
US patent 12230379 (Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy) held by Iovance Biotherapeutics, Inc. expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Iovance Biotherapeutics, Inc.
- Grant date
- Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K35/13, A61K40/11, A61K40/42, A61P